Risk factors for QTc interval prolongation

CPM Heemskerk; M Pereboom; K van Stralen; Florine Berger; Patricia Bemt; AFM Kuijper; RTM van der Hoeven; AK Mantel-Teeuwisse; ML Becker

doi:10.1007/s00228-017-2381-5

Risk factors for QTc interval prolongation

CPM Heemskerk, M Pereboom, K van Stralen, Florine Berger, Patricia Bemt, AFM Kuijper, RTM van der Hoeven, AK Mantel-Teeuwisse, ML Becker

Pharmacy

Research output: Contribution to journal › Article › Academic › peer-review

71 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	183-191
Number of pages	9
Journal	European Journal of Clinical Pharmacology
Volume	74
Issue number	2
DOIs	https://doi.org/10.1007/s00228-017-2381-5
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1007/s00228-017-2381-5

http://hdl.handle.net/1765/103061

Cite this

@article{ab899f064c684bec9283e9432d71d6d6,

title = "Risk factors for QTc interval prolongation",

author = "CPM Heemskerk and M Pereboom and {van Stralen}, K and Florine Berger and Patricia Bemt and AFM Kuijper and {van der Hoeven}, RTM and AK Mantel-Teeuwisse and ML Becker",

year = "2018",

doi = "10.1007/s00228-017-2381-5",

language = "Undefined/Unknown",

volume = "74",

pages = "183--191",

journal = "European Journal of Clinical Pharmacology",

issn = "0031-6970",

publisher = "Springer Science+Business Media",

number = "2",

}

TY - JOUR

T1 - Risk factors for QTc interval prolongation

AU - Heemskerk, CPM

AU - Pereboom, M

AU - van Stralen, K

AU - Berger, Florine

AU - Bemt, Patricia

AU - Kuijper, AFM

AU - van der Hoeven, RTM

AU - Mantel-Teeuwisse, AK

AU - Becker, ML

PY - 2018

Y1 - 2018

U2 - 10.1007/s00228-017-2381-5

DO - 10.1007/s00228-017-2381-5

M3 - Article

C2 - 29167918

SN - 0031-6970

VL - 74

SP - 183

EP - 191

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

IS - 2

ER -